IGC Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IGC Pharma and other ETFs, options, and stocks.

About IGC

IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. 

CEO
Ram Mukunda
CEORam Mukunda
Employees
70
Employees70
Headquarters
Potomac, Maryland
HeadquartersPotomac, Maryland
Founded
2005
Founded2005
Employees
70
Employees70

IGC Key Statistics

Market cap
28.20M
Market cap28.20M
Price-Earnings ratio
-4.55
Price-Earnings ratio-4.55
Dividend yield
Dividend yield
Average volume
499.32K
Average volume499.32K
High today
$0.2968
High today$0.2968
Low today
$0.278
Low today$0.278
Open price
$0.2876
Open price$0.2876
Volume
155.93K
Volume155.93K
52 Week high
$0.4985
52 Week high$0.4985
52 Week low
$0.242
52 Week low$0.242

Stock Snapshot

The current IGC Pharma(IGC) stock price is $0.28, with a market capitalization of 28.2M. The stock trades at a price-to-earnings (P/E) ratio of -4.55.

As of 2026-05-21, IGC Pharma(IGC) stock has fluctuated between $0.28 and $0.30. The current price stands at $0.28, placing the stock +1.0% above today's low and -5.4% off the high.

IGC Pharma(IGC) shares are trading with a volume of 155.93K, against a daily average of 499.32K.

During the past year, IGC Pharma(IGC) stock moved between $0.24 at its lowest and $0.50 at its peak.

During the past year, IGC Pharma(IGC) stock moved between $0.24 at its lowest and $0.50 at its peak.

IGC News

Business Insider 2d
Andrew Left scrutinized hedge fund deals while cashing hedge fund checks, prosecutors say - Business Insider

...

Andrew Left scrutinized hedge fund deals while cashing hedge fund checks, prosecutors say - Business Insider
TipRanks 6d
IGC Pharma to present new Tau-PET biomarker research at Global Tau conference

IGC Pharma (IGC) announced that it will present new Tau-PET biomarker research at the 2026 Global Tau Conference, taking place May 14-15, 2026, at the Grand Hya...

People also own

Based on the portfolios of people who own IGC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.